Wonderful News - Evista better than Tamoxifen

I believe studies are proving that Evista gives the same protection against recurrance as Tamox, but it has not yet been approved by the FDA for that purpose. They work in basically the same way.



Many oncs are prescribing Evista off-label for post-menopausal hormone+ BC survivors, who simply cannot tolerate the AI's or Tamox.



Let's all keep an eye on this in the coming months.



I also believe there was a time when AI's and Zometa were only given to stage IV patients. Now both are used in early stage breast cancer patients.



I don't have any research on this at my fingertips. So please feel free to offer opposing opinions.



I started with Tamox and gave that up because I was a poor metabolizer. I then went on Arimidex for three years and got to the point that it was effecting my memory and mental functions beyond what I could tolerate.



I also took Zometa 7 treatments at six month intervals for bone strength and because at that time it was thought Zometa would be helpful in preventing recurrance or mets in early stage BC patients. I finished all of those.



I spoke with my onc and consulted with two additional research oncologists (one from NYU and one from Yale) when I was considering switching from Arimidex to Evista and after reviewing my case both consulting oncs and my onc agreed Evista would be a good choice for me.



So, this week I am celebrating five years from my diagnosis and feel this was the right choice for me.



I had a mastectomy with reconstruction, chemo and no radiation

YES Catherine, you are right-----for prevention , as you said.

I asked all 3 of my expert drs at MassGeneral and none would give me Evista ..the horse is out of the barn.